Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 13/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.45 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | CTSB | P07858 | 2/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9223574 | 0.89 | CTSG (0.50) | RENCTSSCTSLCTSBCTSK | |
| SCHEMBL7305886 | 0.87 | CTSS (0.45) | CTSSCTSLCTSBCTSKABCB1 | |
| SCHEMBL9217556 | 0.85 | REN (0.49) | REN | |
| SCHEMBL9223666 | 0.85 | REN (0.49) | REN | |
| SCHEMBL9335616 | 0.83 | LMNA (0.44) | CTSLABCB1 | |
| SCHEMBL7338218 | 0.83 | CTSS (0.45) | CTSSCTSLCTSBCTSKABCB1 | |
| SCHEMBL8442775 | 0.82 | MEN1 (0.49) | CTSSCTSLCTSBCTSKABCB1 | |
| SCHEMBL7304706 | 0.81 | ABCB1 (0.44) | RENCTSSCTSLCTSBCTSK | |
| SCHEMBL7301659 | 0.81 | CTSG (0.46) | CTSSCTSLCTSBCTSKABCB1 | |
| SCHEMBL9223970 | 0.78 | CTSK (0.56) | RENCTSLCTSBCTSKABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5430024-A | Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation | HOFFMANN-LA ROCHE INC. (US) | 1995-07-04 | — | — | US | disclosed |
| US-5273982-A | An amidinoaryleneamidoalkylpiperazinyleneacetic acid | HOFFMANN-LA ROCHE INC. (US) | 1993-12-28 | — | — | US | disclosed |